Answers are grounded in this paper and cite their sources.
Background Receipt of opioids in the emergency department (ED) has been identified as a risk factor for long-term opioid use. Little is known about opioid use patterns in the setting of ureterolithiasis pain management in the ED. Objectives We sought to describe patient- and facility-level factors associated with the administration of intravenous (IV) opioids to patients treated with ketorolac for ureterolithiasis in the ED. Methods Patients with ureterolithiasis treated in the ED and discharged home were identified for inclusion and stratified into groups who received IV opioids plus IV ketorolac or IV ketorolac alone, using a national US ED dataset from 2021 to 2022. Chi square and Fisher's exact tests were used to conduct univariable analysis, and a backwards elimination approach was used for multivariable analysis. Results A total of 127,395 individuals were identified in the dataset for inclusion, of which 59,916 received an IV opioid. Obesity (odds ratio [OR] 1.353), an income level in the 76th-100th percentile (OR 1.341), a history of cancer (OR 1.305), and depression (OR 1.304) occurred more frequently among patients treated with IV opioids. In comparison to facilities in the Northeastern US, facilities in the Western US (OR 1.898), Midwestern US (OR 1.643), and Southern US (OR 1.555) administered IV opioids to patients more often. Conclusions In this study, a multitude of variables were associated with IV opioid use for ureterolithiasis pain management in the ED. These findings suggest that both clinical and contextual variables may influence opioid utilization practices in ureterolithiasis management.
No takes yet. Share an insight, caveat, or question.
Benedetto et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: